| European Case Law Identifier: | ECLI:EP:BA:2013:T059812.20131105 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 05 November 2013 | ||||||||
| Case number: | T 0598/12 | ||||||||
| Application number: | 03017743.0 | ||||||||
| IPC class: | A61K 31/565 A61K 31/585 A61P 15/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | ||||||||
| Applicant name: | Bayer Pharma Aktiengesellschaft | ||||||||
| Opponent name: | Teva Pharmaceutical Industries LTD. Sandoz International GmbH Helm AG Gedeon Richter Plc. Laboratories Léon Farma, S.A. |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request and auxiliary request 1: added matter (Yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t120598eu1.html
Date retrieved: 17 May 2021